Cardinal Health and Allegiance Join the Olympic Team
As an Official Supplier, That Is
SALT LAKE CITY, UT-Cardinal Health, Inc. and its subsidiary Allegiance Healthcare Corporation, have been named as an Official Supplier to the 2002 Olympic and Paralympic Winter Games in Salt Lake City and the 2000, 2002, and 2004 US Olympic Teams in the Healthcare Automation and Distribution category. The agreement with the Olympic Properties of the United States (OPUS) binds the companies to provide a variety of healthcare products and services including:
1. Pharmaceutical and healthcare product distribution and supply chain management systems and services.
2. Healthcare products manufactured by Allegiance including gloves, sterile instruments and surgical supplies, laboratory equipment and supplies, and general medical products.
3. Coordination and inventory management of medical equipment, supplies, and pharmaceuticals donated or loaned by the medical manufacturing industry.
4. Medical equipment and supply utilization reporting.
5. Logistics related to product staging, load-in, replenishment, and load-out for all medical supplies at official Salt Lake Organizing Committee medical sites during the 2002 Games.
Cardinal Health and Allegiance will also support the US Olympic Team and the US Olympic Training Centers through 2004.
Show, Tell, Teach: Elevating EVS Training Through Cognitive Science and Performance Coaching
April 25th 2025Training EVS workers for hygiene excellence demands more than manuals—it requires active engagement, motor skills coaching, and teach-back techniques to reduce HAIs and improve patient outcomes.
The Rise of Disposable Products in Health Care Cleaning and Linens
April 25th 2025Health care-associated infections are driving a shift toward disposable microfiber cloths, mop pads, and curtains—offering infection prevention, regulatory compliance, and operational efficiency in one-time-use solutions.
Phage Therapy’s Future: Tackling Antimicrobial Resistance With Precision Viruses
April 24th 2025Bacteriophage therapy presents a promising alternative to antibiotics, especially as antimicrobial resistance continues to increase. Dr. Ran Nir-Paz discusses its potential, challenges, and future applications in this technology.
Robust infectious disease surveillance, including rapid subtyping of influenza A, is essential for early detection, containment, and public health reporting of novel viral threats.
